MLP AG (MLP) | Finanzwire

Basculer en Français

8296	Companies
114902	Keywords
55328	Articles
62458	Press releases

Home
Companies
MLP AG

PRESS RELEASE

published on 01/25/2024 at 09:01, 9 months 27 days ago

Original-Research: MLP SE (von NuWays AG): BUY
This research report from NuWays AG provides a strong recommendation to BUY MLP SE stocks, with a price target of €11.00 over the next 12 months. The report highlights MLP's strong diversification across business segments, solid profitability projection, tailwinds from new interest rate trends, potential for highly profitable performance fees, and the unlikely downside from the real estate business. The report emphasizes the unjustified valuation of MLP shares, trading at historically low multiples, and recommends adding MLP to NuWays' Alpha List 2024.

MLP SE Stock NuWays AG Research Investment Recommendation Financial Analysis Stock Valuation
PRESS RELEASE

published on 11/10/2023 at 10:01, 1 year ago

Original-Research: MLP SE (von NuWays AG): BUY
PRESS RELEASE

published on 11/09/2023 at 07:31, 1 year ago

MLP SE: '9M: Total revenue hits new record level'
PRESS RELEASE

published on 08/10/2023 at 07:32, 1 year 3 months ago

MLP SE: H1: MLP holds its ground in an environment that remains difficult
PRESS RELEASE

published on 05/17/2023 at 17:37, 1 year 6 months ago

MLP SE: Invitation to the Annual General Meeting of MLP SE published
PRESS RELEASE

published on 05/11/2023 at 07:33, 1 year 6 months ago

MLP SE: Q1: MLP remains on course
PRESS RELEASE

published on 03/09/2023 at 07:31, 1 year 8 months ago

MLP SE: FY 2022: MLP defies difficult environment – 2025 growth course reaffirmed

Accesswire

Published on 11/21/2024 at 13:00, 38 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 38 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 38 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 38 minutes ago

Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 38 minutes ago

Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 23 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 3 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 23 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 31 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 38 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 40 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 18 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 53 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 53 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE